Parkinson's disease may be treatable with two existing antimalaria drugs

An estimated 10 million people worldwide are living with Parkinson's disease, a progressive, neurological disorder that mostly strikes after middle age. The team screened around 1,000 drugs already approved by the Food and Drug Administration (FDA) and found two antimalaria drugs - chloroquine and amodiaquine - that boost both protective effects of Nurr1. The team is already looking for other drugs that may halt or reverse the progress of Parkinson's disease, and they plan to improve the drug design and carry out clinical trials of chloroquine and amodiaquine for treating Parkinson's disease.
Read more: Medical News Today